Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jana Baranova"'
Autor:
Jaroslava Voglová, Daniela Zackova, Lukas Stejskal, Petra Belohlavkova, Dana Srbova, Lukáš Semerád, Jiri Mayer, Tereza Nečasová, Jirina Prochazkova, Petra Čičátková, Hana Klamova, Zuzana Šustková, Tomas Hornak, Jana Baranova, Barbora Weinbergerova
Publikováno v:
Leukemia & Lymphoma. 62:194-202
To evaluate long-term real-life results of dasatinib therapy among chronic phase chronic myeloid leukemia patients resistant or intolerant to imatinib, we retrospectively analyzed data of 118 patients treated in centers participating in the database
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af6543ae31e2e22c6434da67c074cda
https://doi.org/10.1080/10428194.2020.1827242
https://doi.org/10.1080/10428194.2020.1827242
Autor:
Pavel Jindra, Pavel Zak, Zdenek Racil, Jiri Mayer, Petr Cetkovsky, Zdenek Pospisil, Zuzana Šustková, Lukáš Semerád, Tomáš Szotkowski, Barbora Weinbergerova, Zdenek Koristek, Jana Baranova, Jan Novák
Publikováno v:
Acta oncologica (Stockholm, Sweden). 60(6)
The care for younger patients with acute myeloid leukaemia (AML) requires fully equipped medical facilities that have routine experience with the management of this aggressive disorder. Two indepen...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6007f1db6d740bd90cedeb1ba662c887
https://pubmed.ncbi.nlm.nih.gov/34048310
https://pubmed.ncbi.nlm.nih.gov/34048310
Autor:
Lola-Jade Palmieri, Tomas Buchler, Antoine Meyer, Veronika Veskrnova, Ondrej Fiala, Petr Brabec, Jana Baranova, Romain Coriat
Publikováno v:
Cancers; Volume 14; Issue 6; Pages: 1410
The first-line therapy of patients with RAS wild-type (WT) non-resectable metastatic colorectal cancer (mCRC) is usually 5-fluorouracil-based chemotherapy with either bevacizumab or an anti-epidermal growth factor receptor (EGFR). The addition of ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7944fdfc97664149300542cad3a610b3
https://doi.org/10.3390/cancers14061410
https://doi.org/10.3390/cancers14061410
Autor:
Andrea, Demitrovicova, Anna, Liskova, Michal, Valach, Martin, Izakovic, Adriana, Noge, Jana, Baranova, Dagmar, Kalatova, Ludmila, Syrovatkova, Jana, Velicova, Beata, Bugykova, Ivica, Gulasova, Dagmar, Seinova, Gertruda, Mikolasova, Martina, Mutalova, Martina, Pilkova, Ivan, Szabo, Lubica, Findova, Istvan, Madarasz, Martin, Stanzyk, Dagmar, Mikulickova, Maria, Blazekova, Monika, Jankechova, Zuzana, Slezakova, Gabriela, Kuriplachova, Jozef, Visnovsky, Andrea, Obrocnikova, Mathias, Blumm, Bernard, Blumm, Simon, Wolfram, Peter, Zeleny, Jana, Otrubova, Bruno, Rudinsky, Zuzana, Nagyova, Martina, Vravcova, Jozef, Kajaba, Sona, Jexova, Svetoslav, Oravec, Slavomir, Toth, Stanislava, Klobucka, Jana, Gerigh, Frank, Schumann, Robert, Ambra, Peter, Bandura, Christian, Bonnack, Zuzana, Kubisova, Marek, Palo, Erich, Kalavsky, Lubos, Drgona, Rajoo, Mahesvaari, Jan, Riedl
Publikováno v:
Neuro endocrinology letters. 34(Suppl 1)
In this short communication we compared the data of fungaemia cases in Slovak hospitals from 1989-1998 published in 1999-2000 with data from 2005-2011.Risk factors, etiology and outcome of fungaemia between two periods (1989-1998 vs. 2005-2011) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5cd5072f6e9c7b8c8ab08270b1ee52c
https://pubmed.ncbi.nlm.nih.gov/24013604
https://pubmed.ncbi.nlm.nih.gov/24013604